Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Tiotropium Respimat® 2.5mcg solution for inhalation

Brand: Spiriva® Respimat®▼
Indication: Asthma
Disease category: Respiratory system
Commissioning responsibility: CCG
PbR excluded: No


Tiotropium 2.5 micrograms (Spiriva® Respimat®▼) is recommended as add-on maintenance bronchodilator treatment in adult patients with asthma who meet all of the following criteria:
• persistent airflow limitation demonstrated by a FEV1 80% predicted and a ratio ofFEV1/FVC 70% and
• currently treated with the maintenance combination of inhaled corticosteroids (≥ 800 micrograms budesonide/day or equivalent*) and long-acting β2 agonists and
• experienced one or more severe exacerbations in the previous year.


LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

LMMG New Medicine Recommendation - Tiotropium in Asthma

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG